Biohaven

Biohaven FCF Yield

The Free Cash Flow Yield of Biohaven (BHVN) as of Nov 13, 2026 is -36.99 %. In the previous year, Free Cash Flow Yield was -35.56 % — a change of 4.03% (lower).

FCF Yield

-36.99 %

YoY

4.03%

Last updated:

Free Cash Flow Yield of Biohaven is 2025 -36.99 % . Free Cash Flow Yield of Biohaven was 2024 -35.56 % . It decreases by 4.03% lower compared to the previous year.

The Biohaven FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
-12.21 USD
Jan 1, 2019
-23.03 USD
Jan 1, 2020
-4.77 USD
Jan 1, 2021
-8.90 USD
Jan 1, 2022
-20.54 USD
Jan 1, 2023
-20.30 USD
Jan 1, 2024
-35.56 USD
Jan 1, 2025
-36.99 USD
The Biohaven FCF Yield history
YEARFCF YieldYoY
-36.99 %+4.03%
-35.56 %+75.19%
-20.30 %-1.18%
-20.54 %+130.80%
-8.90 %+86.61%
-4.77 %-79.29%
-23.03 %+88.70%
-12.21 %+111.11%
-5.78 %+222.91%
-1.79 %+424.51%
-0.34 %+381.20%
-0.07 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biohaven Stock analysis

What does Biohaven do? Biohaven Pharmaceutical Holding Co. Ltd. generates revenue through the research and development of late-stage product candidates targeting neurological diseases and rare disorders. The company utilizes its glutamate platform to advance clinical-stage compounds for various indications, including trigriluzole for obsessive-compulsive disorder, spinocerebellar ataxia, and Alzheimer's disease. Additionally, the firm develops BHV-0223 for amyotrophic lateral sclerosis and BHV-5000 for conditions such as Rett syndrome, neuropathic pain, and treatment-resistant depression. The business model focuses on identifying and developing clinical-stage compounds that target orphan neurologic indications and other neurological pathways, with the company currently employing 825 full-time employees in New Haven, Connecticut. Biohaven is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biohaven stock

Free Cash Flow Yield of Biohaven is -36.99 % in 2025.

Free Cash Flow Yield of Biohaven changed from -35.56 % to -36.99 %, representing a 4.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Biohaven since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Biohaven with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Biohaven

All Key Metrics — Biohaven